Birdwatch Note
2024-04-29 23:15:27 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
まず副反応疑い報告は因果関係があるか分からない事例や直ちに判断できない事例も報告対象です https://www.mhlw.go.jp/bunya/kenkou/kekkaku-kansenshou20/hukuhannou_houkoku/dl/wakuchin.pdf のであらゆる疾患が列挙されています。 https://www.mhlw.go.jp/content/10601000/000914314.pdf 卵巣癌は2億回以上を接種した22年の春時点でもこの副反応疑い報告にすら3回しか挙げられていません。 (下記37P,53P https://www.mhlw.go.jp/content/10601000/000914314.pdf 卵巣に蓄積の噂に関してはよくファクトチェックされており、この話は48時間、投与後の生体内の薬物分布が調べられた調査において卵巣にも0.1%未満分布した量があったという話で、長期蓄積がわかった訳でもなければ特に分布量が多かった臓器でもありません。 以下これを含めた厚労省による不妊卵巣関連QAです https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/vaccine_qa_archive.html#truth_3
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1784931809421332598
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1785085518407143922
- noteId - 1785085518407143922
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1714432527532
- tweetId - 1784931809421332598
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- まず副反応疑い報告は因果関係があるか分からない事例や直ちに判断できない事例も報告対象です https://www.mhlw.go.jp/bunya/kenkou/kekkaku-kansenshou20/hukuhannou_houkoku/dl/wakuchin.pdf のであらゆる疾患が列挙されています。 https://www.mhlw.go.jp/content/10601000/000914314.pdf 卵巣癌は2億回以上を接種した22年の春時点でもこの副反応疑い報告にすら3回しか挙げられていません。 (下記37P,53P https://www.mhlw.go.jp/content/10601000/000914314.pdf 卵巣に蓄積の噂に関してはよくファクトチェックされており、この話は48時間、投与後の生体内の薬物分布が調べられた調査において卵巣にも0.1%未満分布した量があったという話で、長期蓄積がわかった訳でもなければ特に分布量が多かった臓器でもありません。 以下これを含めた厚労省による不妊卵巣関連QAです https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/vaccine_qa_archive.html#truth_3
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2024-04-29 23:15:27 UTC (1714432527532) |
2024-04-30 06:18:49 UTC (1714457929791) |
CURRENTLY_RATED_HELPFUL | 2024-05-01 12:35:12 UTC (1714566912495) |
NEEDS_MORE_RATINGS | 2024-04-30 06:18:49 UTC (1714457929791) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2024-04-30 17:50:23 -0500 | Rating Details | |
2024-04-30 10:06:41 -0500 | Rating Details | |
2024-04-30 05:10:15 -0500 | Rating Details | |
2024-04-30 04:23:34 -0500 | Rating Details | |
2024-04-30 03:48:35 -0500 | Rating Details | |
2024-04-30 01:25:51 -0500 | Rating Details | |
2024-04-30 00:16:14 -0500 | Rating Details | |
2024-04-29 22:53:09 -0500 | Rating Details | |
2024-04-29 22:26:10 -0500 | Rating Details | |
2024-04-29 21:47:46 -0500 | Rating Details | |
2024-04-29 21:42:41 -0500 | Rating Details | |
2024-04-29 21:26:01 -0500 | Rating Details | |
2024-04-29 21:09:39 -0500 | Rating Details | |
2024-04-29 20:56:01 -0500 | Rating Details | |
2024-04-29 20:53:54 -0500 | Rating Details | |
2024-04-29 20:46:34 -0500 | Rating Details | |
2024-04-29 20:26:39 -0500 | Rating Details | |
2024-04-29 20:12:16 -0500 | Rating Details | |
2024-04-29 19:54:07 -0500 | Rating Details | |
2024-04-29 19:45:50 -0500 | Rating Details | |
2024-04-29 19:36:34 -0500 | Rating Details | |
2024-04-29 19:22:01 -0500 | Rating Details | |
2024-04-29 19:17:52 -0500 | Rating Details | |
2024-04-29 19:14:36 -0500 | Rating Details | |
2024-04-29 19:10:22 -0500 | Rating Details | |
2024-04-29 19:10:19 -0500 | Rating Details | |
2024-04-29 19:02:57 -0500 | Rating Details | |
2024-04-29 19:02:40 -0500 | Rating Details | |
2024-04-29 19:01:04 -0500 | Rating Details | |
2024-04-29 18:56:58 -0500 | Rating Details | |
2024-04-29 18:54:00 -0500 | Rating Details | |
2024-04-29 18:46:08 -0500 | Rating Details | |
2024-04-30 20:22:21 -0500 | Rating Details | |
2024-04-30 12:51:52 -0500 | Rating Details | |
2024-04-30 07:47:36 -0500 | Rating Details | |
2024-04-30 07:24:52 -0500 | Rating Details | |
2024-04-30 05:08:51 -0500 | Rating Details | |
2024-04-30 01:59:01 -0500 | Rating Details | |
2024-04-30 01:44:51 -0500 | Rating Details | |
2024-04-30 00:40:47 -0500 | Rating Details | |
2024-04-30 00:08:40 -0500 | Rating Details | |
2024-04-30 00:02:00 -0500 | Rating Details | |
2024-04-29 23:45:18 -0500 | Rating Details | |
2024-04-29 23:26:35 -0500 | Rating Details | |
2024-04-29 23:23:30 -0500 | Rating Details | |
2024-04-29 22:53:28 -0500 | Rating Details | |
2024-04-29 22:10:31 -0500 | Rating Details | |
2024-04-29 21:24:10 -0500 | Rating Details | |
2024-04-29 20:17:41 -0500 | Rating Details | |
2024-04-29 20:14:12 -0500 | Rating Details | |
2024-04-29 20:08:32 -0500 | Rating Details | |
2024-04-29 20:00:40 -0500 | Rating Details | |
2024-04-29 19:37:17 -0500 | Rating Details | |
2024-04-29 19:06:30 -0500 | Rating Details | |
2024-04-29 19:01:34 -0500 | Rating Details | |
2024-04-29 18:58:59 -0500 | Rating Details | |
2024-04-29 18:50:51 -0500 | Rating Details | |
2024-04-29 18:40:45 -0500 | Rating Details | |
2024-04-29 18:37:51 -0500 | Rating Details | |
2024-04-29 18:35:57 -0500 | Rating Details | |
2024-04-29 18:33:44 -0500 | Rating Details | |
2024-05-02 14:58:40 -0500 | Rating Details | |
2024-04-30 05:27:33 -0500 | Rating Details | |
2024-04-30 04:34:59 -0500 | Rating Details | |
2024-04-30 00:08:38 -0500 | Rating Details | |
2024-04-29 23:21:55 -0500 | Rating Details | |
2024-04-29 22:58:59 -0500 | Rating Details | |
2024-04-29 22:42:53 -0500 | Rating Details | |
2024-04-29 22:30:19 -0500 | Rating Details | |
2024-04-29 21:17:41 -0500 | Rating Details | |
2024-04-29 21:09:04 -0500 | Rating Details | |
2024-04-29 21:04:40 -0500 | Rating Details | |
2024-04-29 21:01:53 -0500 | Rating Details | |
2024-04-29 20:40:38 -0500 | Rating Details | |
2024-04-29 20:34:45 -0500 | Rating Details | |
2024-04-29 19:33:57 -0500 | Rating Details | |
2024-04-29 19:31:51 -0500 | Rating Details | |
2024-04-29 19:09:18 -0500 | Rating Details | |
2024-04-29 19:06:38 -0500 | Rating Details | |
2024-04-29 18:50:21 -0500 | Rating Details | |
2024-05-08 21:06:25 -0500 | Rating Details | |
2024-05-01 04:26:07 -0500 | Rating Details | |
2024-04-30 20:27:33 -0500 | Rating Details | |
2024-04-30 02:41:58 -0500 | Rating Details | |
2024-04-29 22:32:56 -0500 | Rating Details | |
2024-04-29 21:57:12 -0500 | Rating Details | |
2024-04-29 21:19:48 -0500 | Rating Details | |
2024-04-29 21:14:07 -0500 | Rating Details | |
2024-04-29 20:45:33 -0500 | Rating Details | |
2024-04-29 20:24:00 -0500 | Rating Details | |
2024-04-29 20:08:18 -0500 | Rating Details | |
2024-04-29 19:58:58 -0500 | Rating Details | |
2024-04-29 19:56:46 -0500 | Rating Details | |
2024-04-29 19:36:31 -0500 | Rating Details | |
2024-04-29 19:21:26 -0500 | Rating Details | |
2024-04-29 18:59:55 -0500 | Rating Details | |
2024-04-29 18:58:46 -0500 | Rating Details | |
2024-04-29 18:52:36 -0500 | Rating Details | |
2024-04-29 18:49:07 -0500 | Rating Details | |
2024-04-29 18:44:58 -0500 | Rating Details | |
2024-04-29 18:44:42 -0500 | Rating Details | |
2024-04-29 18:43:48 -0500 | Rating Details | |
2024-04-29 18:41:38 -0500 | Rating Details | |
2024-04-29 18:39:25 -0500 | Rating Details | |
2024-04-29 18:21:32 -0500 | Rating Details | |
2024-04-29 18:21:25 -0500 | Rating Details | |
2024-05-06 12:22:30 -0500 | Rating Details | |
2024-04-30 00:44:33 -0500 | Rating Details | |
2024-04-29 22:48:47 -0500 | Rating Details | |
2024-04-29 18:41:30 -0500 | Rating Details | |
2024-04-30 03:36:27 -0500 | Rating Details | |
2024-04-30 02:50:05 -0500 | Rating Details | |
2024-04-29 22:32:43 -0500 | Rating Details | |
2024-04-29 22:27:08 -0500 | Rating Details | |
2024-04-29 19:55:07 -0500 | Rating Details | |
2024-04-29 19:09:28 -0500 | Rating Details | |
2024-05-25 04:36:35 -0500 | Rating Details | |
2024-08-21 23:34:35 -0500 | Rating Details |